Advertisement

ACHD Advanced Directives and Discontinuation of Life in the Critical Care Environment

  • Matthias GreutmannEmail author
  • Daniel Tobler
Chapter
Part of the Congenital Heart Disease in Adolescents and Adults book series (CHDAA)

Abstract

A rapidly growing novel cohort of adults with complex congenital heart disease is evolving, many of them at high risk for cardiovascular complications and premature death as young adults. Although there is progress with medical and surgical treatment, caregivers will be inevitably confronted with an increasing number of patients dying under their care. Given their young age, these patients are at high risk of receiving (overly) aggressive or even futile treatments before their demise.

To date, discussions about end-of-life care, advance care planning, and discontinuation of care at the end of life are often avoided for fear of hurting patients’ and their families’ feelings and for uncertainties about the individual patient’s prognosis. This is in contrast with the majority of patients’ wishes to talk about these issues of care. There is in general a substantial lack of knowledge about advance care planning and resources assisting with compiling such documents.

Timely initiation of discussions about advance care planning and encouraging patients to complete advance directives and appoint substitute decision-makers will enhance patient autonomy and may prevent overly aggressive or futile treatment at the end of life.

Keywords

Adult congenital heart disease End-of-life care Care planning Advance directives Palliative care Comprehensive care Prognosis Substitute decision-maker Supportive care 

References

  1. 1.
    Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–72.CrossRefGoogle Scholar
  2. 2.
    Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.CrossRefGoogle Scholar
  3. 3.
    Padrutt M, Bracher I, Bonassin F, Santoslopes B, Gruner C, Stampfli SF, et al. Impact of growing cohorts of adults with con-genital heart disease on clinical workload: a 20-year experience at a tertiary care Centre. Swiss Med Wkly. 2017;147:w14443.PubMedGoogle Scholar
  4. 4.
    Greutmann M, Tobler D, Kovacs AH, Greutmann-Yantiri M, Haile SR, Held L, et al. Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis. 2015;10(2):117–27.CrossRefGoogle Scholar
  5. 5.
    Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000;86(10):1111–6.CrossRefGoogle Scholar
  6. 6.
    Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol. 2007;50(13):1263–71.CrossRefGoogle Scholar
  7. 7.
    Bowater SE, Speakman JK, Thorne SA. End-of-life care in adults with congenital heart disease: now is the time to act. Curr Opin Support Palliat Care. 2013;7(1):8–13.CrossRefGoogle Scholar
  8. 8.
    Tobler D, Greutmann M, Colman JM, Greutmann-Yantiri M, Librach LS, Kovacs AH. End-of-life care in hospitalized adults with complex congenital heart disease: care delayed, care denied. Palliat Med. 2012;26(1):72–9.CrossRefGoogle Scholar
  9. 9.
    Tobler D, Greutmann M, Colman JM, Greutmann-Yantiri M, Librach LS, Kovacs AH. End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol. 2012;155(3):383–7.CrossRefGoogle Scholar
  10. 10.
    Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.CrossRefGoogle Scholar
  11. 11.
    Tobler D, Greutmann M, Colman JM, Greutmann-Yantiri M, Librach SL, Kovacs AH. Knowledge of and preference for advance care planning by adults with congenital heart disease. Am J Cardiol. 2012;109(12):1797–800.CrossRefGoogle Scholar
  12. 12.
    Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386–96.CrossRefGoogle Scholar
  13. 13.
    Greutmann M, Tobler D, Colman JM, Greutmann-Yantiri M, Librach SL, Kovacs AH. Facilitators of and barriers to advance care planning in adult congenital heart disease. Congenit Heart Dis. 2013;8(4):281–8.CrossRefGoogle Scholar
  14. 14.
    Morell E, Wolfe J, Scheurer M, Thiagarajan R, Morin C, Beke DM, et al. Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med. 2012;166(8):745–8.CrossRefGoogle Scholar
  15. 15.
    Masera G, Spinetta JJ, Jankovic M, Ablin AR, D’Angio GJ, Van Dongen-Melman J, et al. Guidelines for assistance to terminally ill children with cancer: a report of the SIOP Working Committee on psychosocial issues in pediatric oncology. Med Pediatr Oncol. 1999;32(1):44–8.CrossRefGoogle Scholar
  16. 16.
    American Academy of Pediatrics. Committee on Bioethics and Committee on Hospital Care. Palliative care for children. Pediatrics. 2000;106(2 Pt 1):351–7.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.University Heart Center, Cardiology, University Hospital ZurichZurichSwitzerland
  2. 2.Department of CardiologyUniversity Hospital BaselBaselSwitzerland

Personalised recommendations